| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/09/2011 | CN101966293A Hemostatic medicament |
| 02/09/2011 | CN101966287A Chinese medicinal pills for nourishing vitality and tonifying blood |
| 02/09/2011 | CN101966283A Traditional Chinese medicine for treating anemia |
| 02/09/2011 | CN101966282A Traditional Chinese medicine for treating stomach diseases |
| 02/09/2011 | CN101966267A Medicament for treating hemolytic anemia |
| 02/09/2011 | CN101966266A Chinese medicinal herb health-care pad for postoperative care |
| 02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
| 02/09/2011 | CN101966243A Method for preparing total anthraquinones of Indian damnacanthus herb |
| 02/09/2011 | CN101966241A Method for detecting medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 02/09/2011 | CN101966233A Preparation method of tuber fleeceflower root formulation granules |
| 02/09/2011 | CN101966223A Fingerprint detection method for compound wintercreeper preparation |
| 02/09/2011 | CN101966199A Application of campanumoea polysaccharide in preparation of medicament and health care food |
| 02/09/2011 | CN101966183A Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 02/09/2011 | CN101664474B Traditional Chinese medicine composition containing instant donkey-hide gelatin powder and preparation method thereof |
| 02/09/2011 | CN101647838B Ginseng donkey-hide gelatin paste preparation technique |
| 02/09/2011 | CN101647837B Production technique for deep processing of active ginseng |
| 02/09/2011 | CN101612324B Medicament for treating cerebral thrombosis |
| 02/09/2011 | CN101427992B Clopidogrel hydrobromate preparation and method of producing the same |
| 02/09/2011 | CN101386635B Method for preparing photo-stable methylamino avermectin |
| 02/09/2011 | CN101352573B Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013668A1 Pharmaceutical composition for treatment of ischemic events |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011012527A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients |
| 02/03/2011 | WO2011012321A1 Processes for crystallization of rivaroxaban |
| 02/03/2011 | US20110028548 Beneficial effects of increasing local blood flow |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028484 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028434 Long-chain polyunsaturated fatty acids (lc-pufa) in maternal nutrition during pregnancy and lactation |
| 02/03/2011 | US20110027867 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
| 02/03/2011 | US20110027378 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027350 Glycopolysialylation of non-blood coagulation proteins |
| 02/03/2011 | US20110027346 Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 02/03/2011 | US20110027337 Protease inhibitor |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027273 Immunotherapy of autoimmune disorders |
| 02/03/2011 | US20110027261 Anti-hepcidin antibodies and uses thereof |
| 02/03/2011 | US20110027258 Modified vitamin k-dependent polypeptides |
| 02/03/2011 | US20110027257 Clottable concentrate of platelet growth factors and preparation method thereof |
| 02/03/2011 | US20110027254 Compositions and methods for treating gaucher disease |
| 02/03/2011 | US20110027223 Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| 02/03/2011 | CA2769258A1 Modified factor ix polypeptides and uses thereof |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2766533A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279734A1 Composition for preventing cardiovascular event in high-risk patient |
| 02/02/2011 | EP2278966A2 Treatment with opioid antagonists and mtor inhibitors |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1899615B Preparation for the prophylaxis of restenose |
| 02/02/2011 | CN1849114B Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 02/02/2011 | CN101965200A Conjugated factor viii molecules |
| 02/02/2011 | CN101962415A Method for preparing low molecular weight brown seaweed fucoidan sulfate |
| 02/02/2011 | CN101961480A Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof |
| 02/02/2011 | CN101961465A Chinese medicament for treating thrombus of portal system |
| 02/02/2011 | CN101961464A Chinese medicinal composition for treating jaundice and preparation method thereof |
| 02/02/2011 | CN101961461A Novel Chinese medicinal material with various effects |
| 02/02/2011 | CN101961459A Oral medicament for treating hemiplegia |
| 02/02/2011 | CN101961414A Medicament for preventing and curing grass carp bleeding disease |
| 02/02/2011 | CN101961391A Traditional Chinese medicine composition for preventing and controlling grass carp disease |
| 02/02/2011 | CN101961381A Preparation method of particles in formula of salvia miltiorrhiza bunge and quality detection method thereof |
| 02/02/2011 | CN101961376A Method for refining sweet basil herb extract |
| 02/02/2011 | CN101961360A Near infrared spectrum identification method for pseudo-ginseng |
| 02/02/2011 | CN101961350A Preparation method of fishy smell-removed pearl powder |
| 02/02/2011 | CN101961310A Preparation technology of ligustrazine hydrochloride injecting liquid |
| 02/02/2011 | CN101961309A Process for preparing pantoprazole sodium for injection |
| 02/02/2011 | CN101961149A Special function nano-element Chinese medicinal water emergency fabric body-building clothes |
| 02/02/2011 | CN101642431B Ozagrel sodium liposome injection |
| 02/02/2011 | CN101518606B Medicament for curing chronic aplastic anemia and preparation method thereof |
| 02/02/2011 | CN101468029B Difructose anhydride-containing composition and use thereof |
| 02/02/2011 | CN101362803B Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/01/2011 | US7879878 Quinolone derivative or salt thereof |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2451206C Urea derivatives with antiproteolytic activity |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2405508C Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 02/01/2011 | CA2403691C The use of cocoa procyanidins combined with acetylsalicylic acid as an anti-platelet therapy |
| 02/01/2011 | CA2380857C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341609C Novel human tissue-type plasminogen activator variant |
| 01/27/2011 | WO2011009601A1 Cell protection in dialysis patients by administration of a creatine compound |
| 01/27/2011 | WO2011009230A1 Pharmaceutical for treating idiopathic edema and preparation methods thereof |
| 01/27/2011 | US20110021981 Methods And Compositions For Treating Trauma-Hemorrhage Using Estrogen And Derivatives Thereof |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021640 Mechanism-based biochemical standardization of resveratrol products and their uses thereof |
| 01/27/2011 | US20110021621 Drug for treating circulatory insufficiency |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |